HFA Premium Access

Myosin heavy chain and MAP-kinase activating death domain-containing gene polymorphisms in adults with hypertrophic cardiomyopathy

Congress Presentation

About the speaker

Miss Anzhelika Polyakova

Almazov National Medical Research Centre, Saint Petersburg (Russian Federation)
0 follower

5 more presentations in this session

Predictors of ICD-related adverse events in patients with hypertrophic cardiomyopathy

Speaker: Mr C. Klein (Lille, FR)

Thumbnail

Impact of hypertrophy in left ventricular ejection fraction and myocardial strain: application of three-dimensional wall-motion tracking technology in hypertrophic cardiomyopathy

Speaker: Doctor L. Marques (Sra. da Hora, PT)

Thumbnail

Assessment of left ventricular strain by three-dimensional wall-motion tracking technology: a study in hypertrophic cardiomyopathy

Speaker: Doctor L. Marques (Sra. da Hora, PT)

Thumbnail

Brain natriuretic peptide level in patients with hypertrophic cardiomyopathy

Speaker: Mrs A. Demkina (Moscow, RU)

Thumbnail

The role of soluble st2 and galectin-3 in hypertrophic cardiomyopathy assessed by cardiac magnetic resonance

Speaker: Doctor M. Gawor (Warsaw, PL)

Thumbnail

Access the full session

Poster Session 4 - Hypertrophic cardiomyopathy

Speakers: Miss A. Polyakova, Mr C. Klein, Doctor L. Marques, Doctor L. Marques, Mrs A. Demkina...
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations